Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spray vs. ointment: which works better for incontinence rash?

NCT ID NCT07637695

Symptom relief Sponsor: Taoyuan Armed Forces General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a silicone barrier spray works as well as a standard zinc oxide ointment for treating mild skin rash caused by incontinence in nursing home residents. Forty participants received one of the two treatments as part of a regular skin care routine. Researchers measured rash severity and skin health at the start, after one week, and after two weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jan 2023

Finished

Nov 2023

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Resident of a long-term care facility. * Diagnosis of mild incontinence-associated dermatitis (IAD), classified as GLOBIAD Category 1. * Ability to provide informed consent personally or through a legally authorized representative. * Willingness to participate in the study and comply with study procedures. Exclusion Criteria: * Incontinence-associated dermatitis (IAD) classified as GLOBIAD Category 2. * Presence of skin erosion, skin loss, open wounds, or active skin infection in the assessment area. * Known allergy or hypersensitivity to silicone-based barrier products or zinc oxide preparations.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dermatitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dermatitis irritant dermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dermatitis Incontinence-associated dermatitis Incontinence-associated dermatitis, dermatitis, skin barrier dysfunction Skin barrier dysfunction

Contacts and locations

Locations

  • Taoyuan Armed Forces General Hospital

    Longtan, Taoyuan City, 325, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.